Skip to main content

Articles

Page 18 of 76

  1. Clear cell renal cell carcinoma (ccRCC) is one of the most lethal malignancies in the urinary system and the existing immunotherapy has not achieved satisfactory outcomes. Therefore, this study aims at establi...

    Authors: Daojia Miao, Jian Shi, Zhiyong Xiong, Wen Xiao, Xiangui Meng, Qingyang Lv, Kairu Xie, Hongmei Yang and Xiaoping Zhang
    Citation: Cancer Cell International 2022 22:66
    Content type: Primary research Published on:

  2. Tumor microenvironments are characterized by resistance to chemotherapeutic agents and radiotherapy. Hypoxia plays an important role in the development of tumor resistance, as well as the generation of metasta...

    Authors: Dengke Zhang, Fazong Wu, Jingjing Song, Miaomiao Meng, Xiaoxi Fan, Chenying Lu, Qiaoyou Weng, Shiji Fang, Liyun Zheng, Bufu Tang, Yang Yang, Jianfei Tu, Min Xu, Zhongwei Zhao and Jiansong Ji
    Citation: Cancer Cell International 2022 22:65
    Content type: Primary research Published on:

  3. Osteosarcoma (OS) is a tumour with a high malignancy level and a poor prognosis. First-line chemotherapy for OS has not been improved for many decades. Bromodomain and extraterminal domain (BET) and histone de...

    Authors: Bo Yu, Lang Liu, Feng Cai, Yuanxiang Peng, Xiaofeng Tang, Duo Zeng, Teng Li, Feifei Zhang, Yiping Liang, Xuhui Yuan, Jiayu Li, Zhengzai Dai, Qi Liao and Xiao-Bin Lv
    Citation: Cancer Cell International 2022 22:64
    Content type: Primary research Published on:

  4. Authors: Feng Qiu, Bin Qiao, Nan Zhang, Zheng Fang, Lu Feng, Shanfeng Zhang and Weiliu Qiu
    Citation: Cancer Cell International 2022 22:63
    Content type: Correction Published on:

    The original article was published in Cancer Cell International 2021 21:412

  5. Head and neck squamous cell carcinoma (HNSCC) is a major threat to public health. Pyroptosis is a form of inflammatory programmed cell death that is still incompletely understood. The role of pyroptotic cell d...

    Authors: Weiwen Zhu, Jiayi Zhang, Mengyao Wang, Rundong Zhai, Yanbin Xu, Jie Wang, Mengqi Wang, Hang Zhang and Laikui Liu
    Citation: Cancer Cell International 2022 22:62
    Content type: Primary research Published on:

  6. Radioiodine (RAI) is the mainstay of treatment for differentiated thyroid carcinoma (DTC) following total thyroidectomy. Nevertheless, about 5% of patients with DTC are RAI-refractory (RAI-R). Understanding th...

    Authors: Hilda Samimi and Vahid Haghpanah
    Citation: Cancer Cell International 2022 22:61
    Content type: Hypothesis Published on:

  7. Present work systematically reviewed relevant literature based on 18F-FDG PET parameters and conducted a meta-analysis to examine the prognostic value of maximal standard uptake value (SUVmax), total lesional ...

    Authors: Weibo Wen, Dongyuan Xu, Yongnan Piao and Xiangdan Li
    Citation: Cancer Cell International 2022 22:60
    Content type: Review Published on:

  8. The prevalence of lung adenocarcinoma (LUAD) has increased, thus novel biomarkers for its early diagnosis is becoming more important than ever. tRNA-derived small RNA (tsRNA) is a new class of non-coding RNA w...

    Authors: Jun Wang, Xianyu Liu, Weifang Cui, Qun Xie, Wei Peng, Heng Zhang, Yang Gao, Chunfang Zhang and Chaojun Duan
    Citation: Cancer Cell International 2022 22:59
    Content type: Primary research Published on:

  9. Colorectal cancer (CRC) has become the second deadliest cancer in the world and severely threatens human health. An increasing number of studies have focused on the role of the RNA helicase DEAD-box (DDX) fami...

    Authors: Xin Zhou, Zhihong Liu, Tengfei He, Cuifeng Zhang, Manman Jiang, Yuxiao Jin, Ziyu Wu, Changji Gu, Wei Zhang and Xiaodong Yang
    Citation: Cancer Cell International 2022 22:58
    Content type: Primary research Published on:

  10. Hepatocellular carcinoma (HCC) often presents with satellite nodules, rendering current curative treatments ineffective in many patients. The heterogeneity of HCC is a major challenge in personalized medicine....

    Authors: Nan Zhao, Yanhui Zhang, Runfen Cheng, Danfang Zhang, Fan Li, Yuhong Guo, Zhiqiang Qiu, Xueyi Dong, Xinchao Ban, Baocun Sun and Xiulan Zhao
    Citation: Cancer Cell International 2022 22:57
    Content type: Primary research Published on:

  13. Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC) are typically characterized by metastasis and chemoresistance. Cell lines are important model systems for developing new therapeutic s...

    Authors: Eva-Maria Packeiser, Leila Taher, Weibo Kong, Mathias Ernst, Julia Beck, Marion Hewicker-Trautwein, Bertram Brenig, Ekkehard Schütz, Hugo Murua Escobar and Ingo Nolte
    Citation: Cancer Cell International 2022 22:54
    Content type: Primary research Published on:

  14. Cysteine cathepsin C encoded by the CTSC gene is an important member of the cysteine cathepsin family that plays a key role regulation of many types of tumors. However, whether CTSC is involved in the pathologica...

    Authors: Xingbo Cheng, Zhishuai Ren, Zhendong Liu, Xiang Sun, Rongjun Qian, Chen Cao, Binfeng Liu, Jialin Wang, Hongbo Wang, Yuqi Guo and Yanzheng Gao
    Citation: Cancer Cell International 2022 22:53
    Content type: Primary research Published on:

  15. Triple-receptor negative breast cancer (TNBC) is an aggressive breast tumor subtype that generally has a poor prognosis. This study aimed to investigate the role and regulatory mechanisms of Zinc finger MIZ-ty...

    Authors: Xiaopan Zou, Yan Liu, Jun Di, Wei Wei, Nobumoto Watanabe, Jiang Li and Xiaomeng Li
    Citation: Cancer Cell International 2022 22:52
    Content type: Primary Research Published on:

  16. Colorectal cancer (CRC) is a malignant tumor affecting people worldwide. Long noncoding RNAs (lncRNAs) is a crucial factor modulating various cancer progression, including CRC. Long intergenic non-protein codi...

    Authors: Shoushan Nan, Shuangxia Zhang, Rong Jin and Juelei Wang
    Citation: Cancer Cell International 2022 22:51
    Content type: Primary research Published on:

  17. Gastric cancer (GC) has a poor prognosis and limited therapeutic options. As a new promising cancer therapeutic approach, chimeric antigen receptor (CAR)-T cells represent a potential GC treatment. We investig...

    Authors: Fengqiang Sun, Xiaomei Yu, Ruixue Ju, Zhanzhao Wang and Yuhui Wang
    Citation: Cancer Cell International 2022 22:50
    Content type: Primary research Published on:

  18. The function of spindle apparatus coiled-coil protein 1 (SPDL1) as a cancer-promoting gene has been reported in a number of studies. However, the pan-cancer analysis of SPDL1 is still lacking. Here, we perform...

    Authors: Peng Song, Dilinaer Wusiman, Fenglan Li, Xiaoxuan Wu, Lei Guo, Wenbin Li, Shugeng Gao and Jie He
    Citation: Cancer Cell International 2022 22:49
    Content type: Primary research Published on:

  19. N6-Methyladenosine (m6A), the most abundant internal modification associated with eukaryotic mRNAs, has emerged as a dynamic regulatory mechanism controlling the expression of genes involved in many physiologica....

    Authors: Shanshan Wang, Wei Lv, Tao Li, Shubing Zhang, Huihui Wang, Xuemei Li, Lianzi Wang, Dongyue Ma, Yan Zang, Jilong Shen, Yuanhong Xu and Wei Wei
    Citation: Cancer Cell International 2022 22:48
    Content type: Review Published on:

  20. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and one of the major causes of cancer-related death. Thymidylate synthase (TYMS) catalyzes the methylation of deoxy guanosine to d...

    Authors: Liang Wang, Caiyan Shi, Jie Yu and Yilin Xu
    Citation: Cancer Cell International 2022 22:47
    Content type: Primary Research Published on:

    The Correction to this article has been published in Cancer Cell International 2022 22:384

  21. Authors: Fan Luo, Jiaxin Cao, Feiteng Lu, Kangmei Zeng, Wenjuan Ma, Yan Huang, Li Zhang and Hongyun Zhao
    Citation: Cancer Cell International 2022 22:46
    Content type: Correction Published on:

    The original article was published in Cancer Cell International 2021 21:458

  22. Authors: Ishita Gupta, Gheyath K. Nasrallah, Anju Sharma, Ayesha Jabeen, Maria K. Smatti, Hamda A. Al-Thawadi, Ali A. Sultan, Moussa Alkhalaf, Semir Vranic and Ala-Eddin Al Moustafa
    Citation: Cancer Cell International 2022 22:45
    Content type: Correction Published on:

    The original article was published in Cancer Cell International 2020 20:107

  23. Malignant melanoma (MM) is highly metastatic and has the highest mortality rate in patients with skin cancer. The ERBB3 binding protein 1 (Ebp1) has been linked to the onset and progression of a number of mali...

    Authors: Yanqiu Bao, Jingshu Cui, Yuyang Yue, Shuxia Cao, Xiangdan Li and Lan Liu
    Citation: Cancer Cell International 2022 22:44
    Content type: Primary research Published on:

  24. N-[2-(5-methoxy-1H-indol-3-yl) ethyl] or simply melatonin is a biogenic amine produced by pineal gland and recently recognized various other organs. Because of a broad range of biological function melatonin is co...

    Authors: Mohammad Mirza-Aghazadeh-Attari, Ainaz Mihanfar, Bahman Yousefi and Maryam Majidinia
    Citation: Cancer Cell International 2022 22:43
    Content type: Review Published on:

  25. Despite advances in the development of efficient chemotherapy, the treatment of colorectal cancer (CRC) remains a challenge due to acquired chemoresistance. It has been reported that microRNAs (miRNAs) dysregu...

    Authors: Hu Han, Yan Li, Wan Qin, Lu Wang, Han Yin, Beibei Su and Xianglin Yuan
    Citation: Cancer Cell International 2022 22:42
    Content type: Primary research Published on:

  27. Rearrangements involving the fibroblast growth factor receptor 1 (FGFR1) gene result in 8p11 myeloproliferative syndrome (EMS), which is a rare and aggressive hematological malignancy that is often initially d...

    Authors: Xuehong Zhang, Furong Wang, Fanzhi Yan, Dan Huang, Haina Wang, Beibei Gao, Yuan Gao, Zhijie Hou, Jiacheng Lou, Weiling Li and Jinsong Yan
    Citation: Cancer Cell International 2022 22:40
    Content type: Primary research Published on:

  28. Theabrownin (TB) is a bioactive component of tea and has been reported to exert effects against many human cancers, but its efficacy and mechanism on hepatocellular carcinoma (HCC) with different p53 genotypes...

    Authors: Jiaan Xu, Xiujuan Xiao, Bo Yan, Qiang Yuan, Xiaoqiao Dong, Quan Du, Jin Zhang, Letian Shan, Zhishan Ding, Li Zhou and Thomas Efferth
    Citation: Cancer Cell International 2022 22:39
    Content type: Primary research Published on:

  29. The tumour heterogeneous make-up of immune cell infiltrates is a key factor for the therapy response and prognosis of hepatocellular carcinoma (HCC). However, it is still a major challenge to comprehensively u...

    Authors: Juan Lu, Yanfei Chen, Xiaoqian Zhang, Jing Guo, Kaijin Xu and Lanjuan Li
    Citation: Cancer Cell International 2022 22:38
    Content type: Primary research Published on:

  31. To determine whether concurrent chemotherapy is necessary during locoregional radiotherapy (RT) after palliative chemotherapy (PCT) in patients with de novo metastatic nasopharyngeal carcinoma (mNPC).

    Authors: Shuo-Han Zheng, Yu-Tong Wang, Song-Ran Liu, Zi-Lu Huang, Guan-Nan Wang, Jin-Tao Lin, Shi-Rong Ding, Chen Chen and Yun-Fei Xia
    Citation: Cancer Cell International 2022 22:36
    Content type: Primary research Published on:

  32. Golgi phosphoprotein 3 (GOLPH3) has been frequently reported as an oncoprotein in a variety of tumors. However, its role in the cancer-associated intercellular signaling communication has not yet been explored...

    Authors: Ying Gao, Zheng Yin, Yunling Qi, Hong Peng, Wenbin Ma, Ruizhi Wang and Wen Li
    Citation: Cancer Cell International 2022 22:35
    Content type: Primary research Published on:

  33. Silencing of the periostin gene (POSTN) can inhibit the biological process of several different cancers, and this inhibition may be related to down-regulation of PI3K/AKT signaling. However, the effect of POSTN o...

    Authors: Chaojian Xu, Ziyue Wang, Long Zhang, Yi Feng, Jia Lv, Zhuangzhuang Wu, Rong Yang, Taiyong Wu, Jian Li, Ruhao Zhou, Zhi Tian, Junjun Bai, Huadong Zhang, Yanping Lan and Zhi Lv
    Citation: Cancer Cell International 2022 22:34
    Content type: Primary research Published on:

  34. Epigenetic reprogramming reportedly has a crucial role in prostate cancer (PCa) progression. RNA modification is a hot topic in epigenetics, and N6-methyladenosine (m6A) accounts for approximately 60% of RNA c...

    Authors: Yongjun Quan, Xiaodong Zhang and Hao Ping
    Citation: Cancer Cell International 2022 22:33
    Content type: Primary research Published on:

  35. Glioblastoma is one of the most common fatal intracranial malignancies. Lysine-specific demethylase 1 (LSD1) reportedly has therapeutic effects on a variety of tumors. This study explored the therapeutic effec...

    Authors: Wei Li, Bai-sheng Huang, Yuan-yuan Xiong, Li-jian Yang and Li-xiang Wu
    Citation: Cancer Cell International 2022 22:32
    Content type: Primary research Published on:

  36. Non-small cell lung cancer (NSCLC) is still one of the diseases with the highest mortality and morbidity, and lung adenocarcinoma (LUAD) accounts for more than half of all NSCLC cases in most countries. miRNA ...

    Authors: Zijian Ma, Ganyi Chen, Yiqian Chen, Zizhang Guo, Hao Chai, Yu Tang, Lin Zheng, Ke Wei, Chunfeng Pan, Zhifei Ma, Yang Xia and Aiping Zhang
    Citation: Cancer Cell International 2022 22:31
    Content type: Primary research Published on:

  37. Raw areca nut (RAN) consumption induces oral, esophageal and gastric cancers, which are significantly associated with the overexpression of pituitary tumor transforming gene 1/securin and chromosomal instabili...

    Authors: Nabamita Boruah, Chongtham Sovachandra Singh, Pooja Swargiary, Hughbert Dkhar and Anupam Chatterjee
    Citation: Cancer Cell International 2022 22:30
    Content type: Primary research Published on:

  39. Liver is the most common metastatic site of colorectal cancer (CRC) and liver metastasis (LM) determines subsequent treatment as well as prognosis of patients, especially in T1 patients. T1 CRC patients with L...

    Authors: Tenghui Han, Jun Zhu, Xiaoping Chen, Rujie Chen, Yu Jiang, Shuai Wang, Dong Xu, Gang Shen, Jianyong Zheng and Chunsheng Xu
    Citation: Cancer Cell International 2022 22:28
    Content type: Primary research Published on:

  40. Circular RNAs (circRNAs) have emerged as vital regulators of the initiation and progression of diverse kinds of human cancers. In this study, we explored the role of hsa_circ_0000231 and its downstream pathway in...

    Authors: Wei Zhang, Bo Wang, Yilin Lin, Yang Yang, Zhen Zhang, Quan Wang, Haoran Zhang, Kewei Jiang, Yingjiang Ye, Shan Wang and Zhanlong Shen
    Citation: Cancer Cell International 2022 22:27
    Content type: Primary research Published on:

  42. Long noncoding RNAs (lncRNAs) play a critical role in innate and adaptive immune responses. Thus, we aimed to identify ideal subtypes for head and neck squamous cell carcinoma (HNSCC) based on immune-related l...

    Authors: Ruoyan Cao, Lin Cui, Jiayu Zhang, Xianyue Ren, Bin Cheng and Juan Xia
    Citation: Cancer Cell International 2022 22:25
    Content type: Primary research Published on:

  43. The Src homology and collagen 4 (SHC4) is an important intracellular adaptor protein that has been shown to play a pro-cancer role in melanoma and glioma. However, the biological function and detailed mechanis...

    Authors: Xin Zhang, Hongwei Zhang, Zhibin Liao, Jiacheng Zhang, Huifang Liang, Weixing Wang, Jia Yu and Keshuai Dong
    Citation: Cancer Cell International 2022 22:24
    Content type: Primary research Published on:

  44. Krüppel‐like factors (KLFs) are zinc finger proteins which participate in transcriptional gene regulation. Although increasing evidence indicate that KLFs are involved in carcinogenesis and progression, its cl...

    Authors: Ke-Yun Zhu, Yao Tian, Ying-Xi Li, Qing-Xiang Meng, Jie Ge, Xu-Chen Cao, Ti Zhang and Yue Yu
    Citation: Cancer Cell International 2022 22:23
    Content type: Primary research Published on:

  45. In recent years, the Fibrinogen to pre-albumin ratio (FPR) has been reported in many studies to be significantly associated with the prognosis of various cancers. This systematic review and meta-analysis aimed...

    Authors: Baibei Li, Huachu Deng, Ziyan Zhou and Bo Tang
    Citation: Cancer Cell International 2022 22:22
    Content type: Review Published on:

  46. Molecular markers play an important role in predicting clinical outcomes in pancreatic adenocarcinoma (PAAD) patients. Analysis of the ferroptosis-related genes may provide novel potential targets for the prog...

    Authors: Jihua Yang, XiaoHong Wei, Fang Hu, Wei Dong and Liao Sun
    Citation: Cancer Cell International 2022 22:21
    Content type: Primary research Published on:

  48. The roles of Polypyrimidine tract-binding protein 3 (PTBP3) in regulating lung squamous cell carcinoma (LUSC) cells progression is unclear. The aim of this study was to investigate the role of PTBP3 in LUSC.

    Authors: Yingji Chen, Ying Ji, Suo Liu, Yicai Liu, Wei Feng and Longyu Jin
    Citation: Cancer Cell International 2022 22:19
    Content type: Primary research Published on:

  49. Short-term starvation (STS) has gradually been confirmed as a treatment method that synergistically enhances the effect of chemotherapy on malignant tumours. In clinical applications, there are still some limi...

    Authors: Wang Zhi, Suting Li, Yuting Wan, Fuwen Wu and Li Hong
    Citation: Cancer Cell International 2022 22:18
    Content type: Primary research Published on:

    The Correction to this article has been published in Cancer Cell International 2022 22:131

  50. HPV as the main cause of cervical cancer has long been revealed, but the detailed mechanism has not yet been elucidated. The role of testis/cancer antigen in cervical cancer has been revealed. However, there a...

    Authors: Yuanhang Zhu, Chenchen Ren, Li Yang, Zhenan Zhang, Meiyuan Gong and Kebing Chen
    Citation: Cancer Cell International 2022 22:17
    Content type: Primary research Published on:

    The Correction to this article has been published in Cancer Cell International 2022 22:77

Journal cover image
Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

On the blog

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here. 

Cancer Cell International

ISSN: 1475-2867

Contact us